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Left Ventricular Function Before and After Diltiazem in Patients With
Coronary Artery Disease
TOMOYUKI MURAKAMI, MD, OITO M. HESS, MD, HANS P. KRAYENBUEHL, MD
Zurich . Switzerland
Left ventricular contraction, relaxation and ftiastolic
mechanics were investigated before and after intrave-
nous administration of 15 mg of diltiazem in 15 patients
with coronary artery disease. High fidelity left ventric-
ular pressure measurements were performed in all 15
patients, with simultaneous biplane cineangiography in
13. The time constant of left ventricular isovolumic pres-
sure decay was calculated from the linear relation of left
ventricular pressure and its rate of change with time
(negativedP/dt). Frame by frame volumeanalysis through
one cardiac cycle was completed to construct volume-
time and pressure-volume curves before and after the
administration of diltiazem.
After diltiazem, left ventricular peak systolic pressure
decreased from 124 to 113 mm Hg (p < 0.001), while
left ventricular end-diastolic pressure and heart rate were
not altered. Maximal positive dP/dt also remained un-
changed. End-diastolic volume was not changed after
diltiazem, but end-systolic volume increased from 48
Calcium channel antagonists block the slow channel by in-
hibiting the slow inward current carried by calcium ions.
Since calcium ions play an important role in activating con-
tractile proteins, interference with the transport of calcium
ions by these agents produces a negative inotropic effect in
myocardium and vasodilation in vascular smooth muscle .
Diltiazem, one of the calcium antagonists . has recently been
shown to be effective in reducing systolic determinants of
myocardial oxygen consumption and improving exercise
tolerance in patients with coronary artery disease (1-3).
However , there is little information concerning its effects
on left ventricular function, especially on left ventricular
relaxation and diastolic mechanic s, in these patients . Left
ventricular relaxation, or pressure decay , is an energy-de-
pendent process influenced by a complex interaction be-
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to 52 ml/m? (p < 0.025); as a result, ejection fraction
decreased slightly from 57 to 55% (p < 0.025). The time
constant of left ventricular pressure decay and maximal
negative dP/dt decreased from 58 to 54 ms (p < 0.025)
and from -1,404 to -1,321 mm Hg/s (p < 0.025),
respectively. Peak early diastolic filling rate increased
from 621 to 752 mIls (p < 0.01) in association with an
increase in filling volume during the first half of diastole
from 60 to 68% (p < 0.005). No consistent displacement
of the diastolic pressure-volume curve was observed after
diltiazem.
This study indicates that diltiazem reduces afterload
and depresses myocardial contractility in patients with
coronary artery disease. In contrast, it improves left
ventricular relaxation, which may contribute in part to
the enhancement of early diastolic filling. However, left
ventricular passive diastolic properties remain unin-
fluenced.
(] Am CoU Cardiol 1985;5:723-30)
tween loading conditions, inactivation (which is a process
of calcium uptake by the sarcoplasmic reticulum) and the
uniformity of distribution of loading conditions and inac-
tivation (4) . Diltiazem could alter left ventricular relaxation
by affecting some of these determinants of relaxation. More-
over , this alteration in left ventricular relaxation potentially
influences diastolic mechanics, such as diastolic filling and
the pressure-volume relation . Therefore, the purpose of this
study was to evaluate the effect of diltiazem on left ven-
tricular contraction, relaxation and diastolic mechanics in
patients with coronary artery disease .
Methods
Study patients. The subjects of this study were 15 men
with coronary artery disease (>50% diameter narrowing) ;
6 had single vessel, 1 had double vessel and 8 had triple
vessel disease . The mean age was 51 years (range 41 to
63) . Fourteen of the 5 patients had a history of myocardial
infarction (4 anterior and 10 inferior). Informed consent was
obtained from all patients .
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Cardiac catheterization. Patients underwent right and
left heart catheterization in the fasting state. Premedication
consisted of 10 mg of chlordiazepoxide administered orally
1hour before catheterization. Eleven patients were receiving
long-term medication with a beta-receptor blocking agent,
which was discontinued either 24 hours (seven patients) or
12 hours (four patients) before the study. Ten patients were
receiving the calcium antagonist, nifedipine; it was with-
drawn either 24 hours (two patients) or 12 hours (eight
patients) before the study. Eleven patients were taking a
long-acting nitrate; it was withdrawn either 24 hours (1
patient) or 12 hours 00 patients) before the study.
Left ventricular pressure was measured with a Millar
pigtail angiographic micromanometer introduced through
the right femoral artery. Left ventricular pressure, the first
derivative of left ventricular pressure (dP/dt), an intracardiac
phonocardiogram from the micromanometer signal and an
intracardiac electrocardiogram from a right-sided electrode
catheter were recorded at a paper speed of 250 mrnls (Elec-
tronics for Medicine, model VRI2) (Fig. 1). The micro-
manometer pressure tracing was superimposed on the con-
ventional pressure tracing.
Simultaneous biplane left ventricular cineangiography
was performed in the 30° right anterior oblique and 60° left
anterior oblique projections at a filming rate of 50 frames/so
Volumes were calculated using the area-length method. Each
angiographic frame had a digital time that corresponded to
time marks on the pressure recordings.
Study protocol. After placement of the catheters, rou-
tine measurements of right and left heart hemodynamics at
rest were made. Baseline left ventricular angiography and
simultaneous high fidelity left ventricular pressure mea-
surements were then performed. After the first ventriculo-
gram, a pause of 15 minutes was permitted for dissipation
of the hemodynamic and myocardial effects of the contrast
agent. Then 15 mg of diltiazem was injected intravenously
at a rate of 5 mg/min (47 to 77 j.Lg/kg per min). Ten minutes
after the initiation of the injection, intracardiac pressure
measurements and left ventricular cineangiography were re-
peated. The time interval between the first and the second
angiogram was 25 minutes. Two patients were excluded
from the volume analysis because cineangiography had not
been performed at baseline or after diltiazem. All patients
were found to have a left ventricular regional wall motion
abnormality (in 14 patients on the baseline angiogram, and
in 1 who did not undergo baseline angiography on the rest
echocardiogram). Five patients showed akinesia and nine
showed hypokinesia in the regions of the wall corresponding
to those of myocardial infarction; one patient who had not
had a previous myocardial infarction demonstrated anterior
hypokinesia. Finally, coronary arteriography was performed
by the Judkins technique.
Data analysis. All beats analyzed were sinus beats, and
postextrasystolic beats were excluded. Pressure tracings were
digitized for an entire cardiac cycle by an electronic digitizer
(Numonics Corporation) interfaced with a digital computer
(PDP, model 11110). A previously described program (5)
produced a printout of pressure and dP/dt values, dividing
one cardiac cycle into 130 time intervals. The time constant
of isovolumic relaxation and the extrapolated baseline pres-
sure (pressure at dP/dt = 0) were calculated, respectively,
as the negative reciprocal of the slope and the intercept of
the linear regression of pressure and the negative dP/dt co-
ordinates during the isovolumic relaxation period. The iso-
volumic relaxation period was defined as the period begin-
ning immediately after maximal negative dP/dt and ending
when pressure decreased to 5 mm Hg above left ventricular
end-diastolic pressure (6). The mean correlation coefficient
of the linear relation between left ventricular pressure and
negative dP/dt was -0.994 both in the control state (range
0.983 to 0.999) and after diltiazem administration (range
0.985 to 0.999). In 13 patients with pressure recordings and
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Figure 1. Pressure tracings in the
control state and 10 minutes after 15
mg of diltiazem intravenously (I. V.).
In this patient, left ventricular peak
pressure (LVP) decreased by 16 mm
Hg after the administration of dilti-
azem. End-diastolic pressure did not
change. ECG = electrocardiogram;
MUs = muscle lengths per second;
PCG = phonocardiogram; RVP =
right ventricular pressure; VCE = the
first derivative of left ventricular pres-
sure (dP/dt) divided by pressure (P).
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simultaneous cineangiography, volume-time and pressure-
volume curves were constructed every 20 ms throughout
one cardiac cycle in the baseline state and after diltiazem
administration. Stroke work (SW) in g/rn? was calculated
from the equation: SW = A x 0.0136, where A is the area
enclosed by the pressure-volume loop as determined by
planimetry. In this study, the time of end-diastole was de-
fined as the beginning of the rapid increase in left ventricular
pressure immediately after the onset of the QRS complex.
End-systole was defined as the angiographically determined
point of aortic valve closure or the point of the second heart
sound.
The method for analyzing diastolic mechanics has been
reported previously (7). The time of mitral valve opening
was 20 ms before the first frame showing the entry of un-
opacified blood into the left ventricle; the pressure at this
timing was termed' 'mitral opening pressure" and was con-
sidered to be an index of atrial driving pressure. The time
interval from mitral valve opening to end-diastole was taken
as the left ventricular filling time. This filling time was
divided into a first and second half; mid-diastolic pressure
and volume and the ratio of the volume increase during the
first and second half of diastole to the total filling volume
(maximal diastolic volume minus volume at mitral valve
opening) were calculated. In addition, instantaneous dia-
stolic filling rates were calculated every 20 ms after mitral
valve opening. To minimize error due to random noise in
the left ventricular volume curve, raw data were smoothed
by the convolution method (8) according to the formula:
Vet) = [vet - 20) + 2'v(t) + vet + 20)]/4, where t is
the time from mitral valve opening (ms), and vet) and Vet)
are raw and smoothed instantaneous left ventricular volume
(ml), respectively. Then diastolic filling rate (fr) at time t
was calculated (in mils) from the equation: fret) = [Vet +
20) - Vet - 20)]/0.04. The greatest value occurring early
in diastole was termed the "peak filling rate." Pressures
and volumes at three diastolic points (lowest diastolic pres-
sure, mid-diastole and end-diastole) were averaged, and the
mean diastolic pressure-volume curve was constructed. End-
diastolic volume index, end-systolic volume index and ejec-
tion fraction were calculated in the usual fashion.
Statistics. Comparisons of hemodynamic and angio-
graphic variables between the control state and diltiazem
administration were performed by a paired t test. Differences
were considered significant when the p value was less than
0.05. Data are presented as mean values ± I standard
deviation.
Results
Left ventricular pressure and relaxation data are presented
in Table I, and volume data and data obtained from pres-
sure-volume loops in Table 2. Figure I demonstrates rep-
resentative pressure tracings. Examples of pressure-dP/dt,
volume-time and pressure-volume relations in the same pa-
tient are shown in Figures 2 and 3.
Systolic function. Left ventricular systolic pressure de-
creased from 124 to 113 mm Hg (p < 0.001) after the
Table 1. Left Ventricular Pressure and Derived Data in 15 Patients
HR LVEDP LVSP LVESP +dP/dt max -dP/dt max T PB
(min I) (mm Hg) (mm Hg) (mm Hg) (mm Hg/s) (mm Hg/s) (ms) (rnm Hg)
Case C D C D C D C D C D C D C D C D
I 64 65 4 5 110 106 9X X6 1.182 1.126 1,240 1,226 61 50 -18 -12
2 55 61 II 13 105 97 94 X2 1.306 1.132 1,178 1,191 55 50 -13 - 9
3 75 64 14 16 108 9X lOX X3 1,281 1.174 1,071 1.058 62 55 - 9 - 6
4 67 55 14 13 143 113 83 76 1,501 1.303 1.301 1.071 97 94 -38 -32
5 68 71 26 23 166 ISO 114 90 1.535 1,496 1,841 1.598 53 51 -IS -10
6 53 53 14 18 126 124 III lOX 1,360 1.366 1,494 1,414 51 51 -II - 8
7 54 50 17 17 139 130 86 S2 1.326 1,290 1.313 1.323 65 54 -12 - 7
8 82 80 14 15 118 9S X5 72 1.601 1,402 1.502 1,261 45 44 - 6 - 5
9 64 61 6 8 112 lOS 86 XS 1,449 1,365 1.383 1.365 56 54 -12 -10
10 67 68 10 6 124 liS 102 85 1.207 1,297 1,481 1,422 59 51 -II -10
II 74 75 II II 131 126 87 90 1,418 1,396 1.571 1,628 45 40 - 8 - 7
12 61 60 13 10 114 95 81 70 1,423 1.141 1.395 1.116 43 51 - I - 4
13 81 81 3 6 113 114 96 94 1.533 1.7X7 1.399 1,385 48 50 -13 -16
14 62 74 12 13 141 112 X3 6X 1.376 1.346 1,526 1.367 71 56 -20 -10
15 78 72 7 14 112 110 74 73 1,476 1,430 1.365 1,386 54 54 -10 -10
Mean 67 66 12 13 124 113 93 83 1.398 1,394 1,404 1,321 58 54 -13 -10
±SD ±9 ±IO ±6 ±5 ± 17 ± 15 ±12 ± II ± 123 ± 160 ± 183 ± 170 ± 13 ±12 ±8 ±7
p Value NS NS <0.001 «o.co: NS <0.025 <0.025 <0.01
Data are presented in the control state (C) and after the administration of diltiazem (D). HR = heart rate; LVEDP = left ventricular end-diastolic
pressure; LVESP = left ventricular end-systolic pressure; LVSP = left ventricular systolic pressure; PR = extrapolated baseline pressure; T = time
constant of the decrease in left ventricular pressure.
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Table 2. Angiographic and Derived Data in 13 Patients
EDV ESV EF SW fp TFV VI V2
(ml/nr') (rnl/rrr') (%) (g/m 2) (mils) (mil (%) (%)
Case C D C D C D C D C D C D C D C D
3 116 113 52 52 55 54 83 55 575 625 119 116 63 72 37 28
4 135 125 71 70 47 44 74 60 600 750 138 126 69 72 31 28
5 102 101 41 42 60 58 110 98 775 875 122 120 65 65 35 35
6 103 106 37 40 64 62 83 82 500 675 127 130 65 68 35 32
7 140 144 61 70 56 52 107 97 700 775 137 135 61 66 39 34
8 III 122 47 55 58 55 75 82 650 850 120 125 60 73 40 27
9 94 87 31 37 67 58 44 30 500 475 99 85 54 71 45 29
10 159 161 67 65 58 60 86 78 1.\75 \,050 170 177 76 76 24 24
II 108 114 45 48 59 58 87 78 675 825 118 113 60 65 40 35
12 III 107 49 49 56 54 62 55 600 675 108 109 67 67 33 33
13 99 106 44 52 55 51 77 66 400 450 lIS \04 43 54 57 46
14 102 108 42 42 59 62 82 81 525 950 136 145 53 63 47 37
15 87 99 43 50 51 49 57 63 400 800 93 106 48 75 52 25
Mean 113 115 48 52 57 55 79 71 621 752 123 122 60 68 40 32
±SD ±20 ±20 ± 12 ± II ±5 ±5 ± 18 ± 19 ±2oo ± 172 ±30 ±22 ±9 ±6 ±9 ±6
p Value NS <0.025 <0.025 <0.01 <0.01 NS <0.005 <0.005
EDV = end-diastolic volume; EF = ejection fraction; ESV = end-systolic volume; fp = peak filling rate; SW = stroke work; TFV = total filling
volume; VJ and V2 = % volume increase during the first and the second half of diastole, respectively. Other abbreviations as in Table I.
in association with a significant decrease in end-systolic
pressure from 93 to 83 mm Hg (p < 0.001). As a result,
ejection fraction slightly decreased from 57 to 55% (p <
0.025). Maximal positive dP/dt decreased slightly but not
significantly from 1,398 to 1,349 mm Hg/s. Diltiazem low-
ered stroke work from 79 to 71 g/m? (p < 0.01).
Isovolumic relaxation. Peak negative dP/dt decreased
from -1,404 to -1,321 mm Hg/s (p < 0.025). The time
constant of left ventricular relaxation decreased from 58 to
54 ms (p < 0.025) and extrapolated baseline pressure in-
creased from -13 to -10 mm Hg (p < 0.01) after the
administration of diltiazem.
Diastolic mechanics. Diltiazem enhanced early dia-
stolic filling. It caused an increase in peak early diastolic
filling rate from 621 to 752 mIls (p < 0.01) and percent of
filling volume during the first half of diastole from 60 to
68% (p < 0.005). Total filling volume did not change.
Although there was no significant change in either mitral
opening pressure or lowest diastolic pressure after the
administration of diltiazem, mid-diastolic pressure increased
from 5 to 8 mm Hg (p < 0.01). Volumes at both lowest
diastolic pressure and mid-diastole were augmented from
136 to 148 ml (p < 0.025) and from 177 to 193 ml (p <
0.005), respectively (Table 3).
Diltiazem did not displace significantly either the position
or the slope of the mean diastolic pressure-volume curve
(Fig. 4). Four patients showed a slight rightward shift of
the entire pressure-volume loop (Fig. 3).
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administration of diltiazem, while end-diastolic pressure and
heart rate did not change. Although end-diastolic volume
remained unchanged after diltiazem administration, end-
systolic volume increased from 48 to 52 ml/rrr' (p < 0.025)
Figure 2. Relation between negative dP/dt and pressure. Left
ventricular (LV) pressure and negative dP/dt coordinates from the
isovolumic relaxation period are shown. The time constant (T) of
relaxation and the extrapolated baseline pressure (Po) are derived
from the linear relation of pressure and negative dP/dt as its re-
ciprocal of the slope and its intercept at dP/dt = O. In this case,
diltiazem decreased the time constant from 67 to 54 ms and in-
creased the extrapolated baseline pressure from - 12 to - 7 mm
Hg.
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chronotropic effects may vary depending on the drug used
and its dosage (9). Under conditions of the present study,
our data demonstrate that diltiazem reduces afterload, but
does not alter either preload or heart rate. Although left
ventricular regional function was not assessed in this study,
it seems that diltiazem depresses myocardial contractility
because end-systolic volume increased and ejection fraction
decreased despite a reduction in afterload. An increase in
end-systolic volume in association with a decrease in end-
systolic pressure (right downward shift of the end-systolic
pressure-volume relation) also suggests depressed myo-
cardial contractility after diltiazem administration.
It is possible that the observed negative inotropic effect
of diltiazem is pronounced during intravenous injection and
different from the effect of oral administration; thus, further
investigation is required regarding such a difference. The
dosage of diltiazem used in the study is, however, thought
to be sufficient to inhibit the myocardial activation process,
which may result from a reduction in the concentration of
intracellular calcium ions due to interference in the transport
of these ions by diltiazem. As is indicated by a reduction
in stroke work, the effects of diltiazem on systolic perform-
ance apparently contribute in reducing the determinants of
Figure 3. Volume-time (left) and pressure-volume (right) curves
through one complete cardiac cycle for the same patient are shown.
Left, Left ventricular (LV) filling time from the mitral valve open-
ing (MVO) and the subsequent end-diastole (ED) were divided
into the first (t.) and second (t2) half of diastole. The ratio of
volume increase during each filling period to total filling volume
(maximal diastolic volume minus volume at mitral valve opening)
was also calculated (V, and V2) . After diltiazem, the peak filling
rate increased from 700 to 775 mils and was associated with an
augmentation of the percent volume increase during the first half
of diastole from 60 to 68%. Right,The pressure-volume loop was
shifted slightly rightward, reflecting depressed systolic perform-
ance after diltiazem in this patient. However, its diastolic portion
was not shifted significantly. ES = end-systole.
myocardial oxygen consumption in patients with coronary
artery disease. Another important determinant of myocardial
oxygen consumption, peak systolic wall stress, is unlikely
to change after the administration of diltiazem because the
decrease in left ventricular systolic pressure may be antag-
onized by the increase in left ventricular end-systolic
dimension.
Isovolumic relaxation. In conscious dogs, Karlineret al.
(10) demonstrated that factors that augment the extent and
Table 3. Diastolic Pressure and Volume Data in 13 Patients
Mitral Lowest Volume at Pressure Volume
Opening Diastolic Lowest at Mid- at Mid-
Pressure Pressure Pressure Diastole Diastole
(mm Hg) (mm Hg) (rnl) (mm Hg) (rnl)
Control 16 ± 10 3 ± 4 136 ± 36 5 ± 8 177 ± 40
Diltiazem 18 ± 7 4 ± 4 148 ± 33 8 ± 4 193 ± 36
p Value NS NS <0.025 <0.01 <0.OD5
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tivity depending on the vasodilative effect of each agent.
Therefore, although contractile function was depressed and
heart rate was unaltered after the administration of diltiazem
in this study, it is possible that augmented sympathetic nerve
activation due to afterload reduction minimizes more pro-
found negative inotropic and masks negative chronotropic
effects that are produced primarily by diltiazem adminis-
tration. The decrease in the time constant of left ventricular
pressure decay despite an increased end-systolic volume
suggests that accelerated inactivation is a prominent effect
with the dose of diltiazem used in this study.
Our data demonstrate an opposite tendency of the di-
rections of changes in the time constant and another index
of pressure decay, namely, maximal negative dP/dt. It is
unlikely that the mathematical model we used is inappro-
priate for calculating a time constant because we observed
a high correlation in the linear relation between pressures
and negative dP/dt. However, previous investigators (10, 13)
pointed out that maximal negative dP/dt is primarily influ-
enced by the level of aortic pressure and is not a valid
measure of left ventricular relaxation during acute altera-
tions in afterload. The decrease in maximal negative dP/dt
that we observed may merely reflect an afterload reduction
caused by diltiazem, and not a slower isovolumic relaxation.
Diltiazem could accelerate relaxation by reducing myo-
cardial ischemia in patients with coronary artery disease.
Although dynamics in coronary circulation were not eval-
uated in this study, previous studies (14,15) have shown
that diltiazem increases coronary blood flow to the suben-
docardium and border ischemic zones in the presence of
coronary artery stenosis in animals. Such an increase in
coronary blood flow with diltiazern, in combination with a
decrease in the determinants of myocardial oxygen con-
sumption as demonstrated in this study, may improve the
imbalance between myocardial oxygen supply and demand
in patients with coronary artery disease and influence iso-
volumic pressure decay in two ways: I) by promoting in-
activation, and 2) by improving asynchronous wall motion
of the left ventricle. However, the presence or absence of
an impairment in the inactivation process or a regional wall
motion abnormality due to a persistent ischemia in our pa-
tients is not certain.
Diastolic filling. There has been considerable contro-
versy over whether or not calcium antagonists can alter the
filling dynamics and contribute to improved cardiac function
in patients with hypertrophic cardiomyopathy. Some inves-
tigators (16-19) showed that verapamil enhances peak early
diastolic filling rate in association with a rapid left ventric-
ular pressure decay, while others (20) demonstrated the
opposite effects .
Diltiazem also enhances early diastolic filling, as sug-
gested by the increases in peak filling rate and percent of
filling volume during the first half of diastole. An early
diastolic phenomenon such as peak filling rate could be
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Figure 4. Left ventricular (LV) diastolic pressure-volume relation
in 13 patients . A mean diastolic pressure-volume curve was con-
structed. Averaged valuesof pressures and volumes werederived
from three diastolic points: the point at the lowestdiastolic pres-
sure, at mid-diastole and at end-diastole. No significant change in
either the position or the slope of the pressure-volume curve was
observedafterdiltiazem,although thepressure-volume coordinates
were shifted slightly upward and to the right.
velocity of myocardial fiber shortening also enhance the rate
of isovolumic left ventricular relaxation. In the intact dog
heart , Gaasch et al. (II) and others (6) found a close relation
between the index of the rate of isovolumic left ventricular
relaxation and end-systolic loading conditions. The data
from these studies suggest that interventions that provide
more deformation of the ventricular shape during contrac-
tion are associated with an increment in the relaxation rate.
Because diltiazem increases end-systolic volume and. thus ,
decreases the magnitude of deformation as the net result of
interaction between negative inotropic effect and afterload
reduction, slower left ventricular relaxation would be ex-
pected to result. In our study , however, diltiazem led to a
decrease in the time constant of relaxation, indicating a more
rapid left ventricular isovolumic pressure decay .
Recently , Brutsaert et al. (4) observed that myocardial
relaxation is regulated by a complex interplay of three major
determinants: load, inactivation and uniformity of distri-
bution of loading conditions. It is possible that a lower
calcium ion concentration in the region of myofibrils , which
results from blockade of calcium entry by diltiazem and
causes an inhibition of activation, in tum , contributes to
rapid uptake of calcium by the sarcoplasmic reticulum (ac-
celeration of inactivation) and thereby augments relaxation.
The potential increase in sympathetic discharge resulting
from the afterload reduction caused by diltiazem may pro-
vide another possible explanation for accelerated relaxation.
Kawai et al. (12) observed a suppressive effect of calcium
channel antagonists (diltiazem, verapamil and nifedipine)
on sinoatrial nodal function experimentally , which is mod-
ified in the clinical setting by augmented sympathetic ac-
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affected by an alteration in isovolumic relaxation; acceler-
ated relaxation by diltiazem may contribute in part to an
enhancement of early diastolic filling. In a recent compar-
ative study on the effects of three calcium channel antag-
onists in conscious and ischemic dogs, Urquhart et al. (9)
observed an increase in peak diastolic filling rate only after
verapamil or nifedipine administration, while they did not
observe such an increase with similar dosages of diltiazem.
The reasons for the discrepancy between their results and
ours might be related to the differences in species, protocol,
relative dosage and methods for evaluation, since in their
study no consistent changes in either systolic (unchanged
global or regional ejection fraction) or diastolic function
were produced by diltiazem.
Left atrial driving pressure has been considered to be
another important determinant of diastolic filling (7). In-
stead of this pressure, we assessed mitral opening pressure,
which is a reasonable alternative to the driving pressure.
However, no significant change was observed in the mitral
opening pressure either before or after diltiazem adminis-
tration. Our data demonstrate that the extrapolated baseline
pressure is increased slightly but significantly after the
administration of diltiazem. Whether or not this increase in
baseline pressure reflects an alteration in relaxation or filling
dynamics is not certain, but it may be due to the reduction
of elastic recoil observed with an increase in end-systolic
volume after diltiazem (21). As described previously (22),
although the extrapolated baseline pressure helps in char-
acterizing isovolumic pressure decay, which is inadequately
predicted by a time constant alone, further work will be
required regarding its physiologic implications.
Diastolic pressure-volume relation. Despite alterations
in isovolumic pressure decay and early diastolic filling, dil-
tiazem administration does not produce a subsequent dis-
placement of diastolic pressure-volume relations. Acceler-
ated relaxation would be expected to displace the diastolic
pressure-volume curve downward. However, the enhanced
filling rate in early diastole after the administration of dil-
tiazem moves the pressure-volume relation upward on the
rest pressure-volume curve. This explains the significant
increase in mid-diastolic pressure and volume after dilti-
azem. There appears to be no significant change in passive
elasticity of the left ventricle after diitiazem since there was
no alteration in the slope of the individual or mean pressure-
volume curves (Fig. 4). In this study, diltiazem displaced
the end-diastolic pressure-volume relation slightly rightward
in four patients and, thus, it may have importantly affected
their left ventricular preload.
The effects of diltiazem observed in this study might
have been influenced by the medications taken by the pa-
tients before entering the study, especially when these had
been withdrawn only 12 hours before the study. No signif-
icantly different responses to diltiazem administration, how-
ever, were observed among patients in whom cardiovascular
medications such as beta-adrenergic blocking agents or cal-
cium channel antagonists had been withdrawn 12 hours be-
fore the study and those who were not taking these medi-
cations or in whom they had been withdrawn 24hours before
the study.
In summary, in patients with coronary artery disease,
diltiazem inhibits myocardial activation but accelerates its
inactivation processes. The former may result in depressed
contractility and the latter in more rapid relaxation of the
left ventricle in association with enhanced early diastolic
filling. These alterations are not accompanied by a change
in the passive diastolic properties of the left ventricle.
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